TA

Timo Ahopelto

Early stage investor and entrepreneur. Co-founder of CRF Health (e-clinical software unicorn) and Lifeline Ventures. Ecosystem work at Slush, ETLA/EVA and FSC.

Helsinki, Uusimaa

Invests in

Stages:

  • Min Investment:

    $660,000.00
  • Max Investment:

    $1,320,000.00
  • Target Investment:

    $990,000.00

Work Experience

  • Founding Partner

    2009

    Early-stage venture fund founded by serial entrepreneurs Timo Ahopelto and Petteri Koponen. Our goal is to be the first person the entrepreneur reaches out to in times of trouble and joy.

2023

  • Board Member

    2023

2015

  • Board Member

    2015

    World's first and only health ring and the most accurate sleep tracker. Personalized guidance to feel and perform better. The first investor in the company.

  • Board Member

    2017

    Solidium is a holding company wholly owned by the State of Finland and a minority owner in nationally important listed companies. The value of the holdings is approximately €7 Bn (Q3/2020).

  • Board Member

    2015

    EVA is a policy and pro-market think tank. EVA’s aim is to identify and evaluate trends that are important for Finnish companies and for the long-term success of the society as a whole. EVA publishes reports and organises events and discussions.

  • Chairperson of the Board

    2013

    The world’s leading wind propulsion technology for shipping. Norsepower Rotor Sails provide a reliable and easy-to-operate auxiliary wind propulsion system with a proven savings record. Norsepower Rotor Sails can typically reduce fuel consumption by 5-20%. The first investor in the company.

2020

  • Board Member

    2020

    The food intelligence company providing VERI service. The first investor.

  • Board Member

    2022

  • Chairperson of the Board

    2016 - 2022

    A leader in software robotics with AI tools embedded. The first investor in the company.

  • Board Member

    2014

    Novel T-cell therapy -enhancing oncolytic immunotherapy moving into clinical trials. The first investor in the company.

  • Board Member

    2012

    Rapid, multianalyte infectious disease diagnostics for point-of-care testing with corona virus included.